Mitsubishi UFJ Trust & Banking’s Relay Therapeutics RLAY Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Buy	+7,110	New	+$103K	﹤0.01%	1453

Other funds holding RLAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's RLAY Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 7,110 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #1453 among its holdings.

74 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 7,110 shares of Relay Therapeutics worth $133K as of Q2 2026.
Relay Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Relay Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1453 holding.
74 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.